Latest News
News Functions
Additional Functions
4 June 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
3 June 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
22 May 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
9 May 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
8 May 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
30 April 2024
Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
Upcoming Events
Latest Reports
News Functions
Additional Functions
26 June 2024
Amphastar Pharmaceuticals, Inc.
June 2024 Corporate Presentation
6 June 2024
Amphastar Pharmaceuticals, Inc.
Presentation
15 May 2024
Amphastar Pharmaceuticals, Inc.
BOFA Presentation
10 May 2024
Amphastar Pharmaceuticals, Inc.
Q1 24 10-Q
8 May 2024
Amphastar Pharmaceuticals, Inc.
Q1 2024 Earnings Presentation
10 April 2024
Amphastar Pharmaceuticals, Inc.
Needham Presentation